title: Neurosurgery for Parkinson's disease.
abstract: Medical therapy for Parkinson's disease (PD) often becomes inadequate over several years. Disability increases despite maximal medical management and many patients develop motor fluctuations and dyskinesia. In addition, medications provide good control of tremor in only 50% of cases. In appropriately selected cases, surgical therapies for PD provide benefit for medically refractory symptoms. Recent advances have provided a greater array of surgical options. Unilateral thalamotomy and thalamic stimulation are considered safe and effective procedures to treat contralateral tremor. Pallidotomy and pallidal stimulation primarily reduce contralateral dyskinesia, with lesser effects on bradykinesia and rigidity. Studies indicate that subthalamic nucleus (STN) stimulation improves "off" period function, decreases "off" time, and lessens dyskinesia. Fetal cell transplantation remains experimental, and studies are underway to evaluate the safety and efficacy of porcine fetal cell and human retinal pigment epithelial cell transplantation. This chapter reviews the history of surgical procedures for PD, describes current procedures, and offers a look into the future of neurosurgical options for PD.
authors.affiliation: Parkinson's Disease and Movement Disorders Center, Department of Neurology, University of South Florida, Tampa 33606, USA.
authors.forename: T A
authors.initials: TA
authors.lastname: Zesiewicz
authors.forename: R A
authors.initials: RA
authors.lastname: Hauser
mesh_terms: D000818:Animals; D001921:Brain / Q000601:surgery*; D017690:Cell Transplantation; D004599:Electric Stimulation Therapy; D016332:Fetal Tissue Transplantation; D006801:Humans; D010300:Parkinson Disease / Q000601:surgery* / Q000628:therapy; D010857:Pigment Epithelium of Eye / Q000166:cytology; D013238:Stereotaxic Techniques; D013552:Swine; D014183:Transplantation, Heterologous